title: Antimicrobial stewardship in immunocompromised hosts.
abstract: The global spread of antimicrobial resistance has limited the availability of antimicrobial agents to treat infections that affect immunocompromised hosts. Efforts to optimize the selection, dosing, and duration of antimicrobial therapy to improve patient outcomes and minimize selective pressure on antimicrobial resistance are relevant to immunocompromised patients. Collaborative efforts between health care providers with expertise in the diagnosis and treatment of patients with various degrees of immunosuppression are pivotal for the success of antimicrobial stewardship programs in immunocompromised patients.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Suite 851, Miami, FL 33136, USA. Electronic address: labbo@med.miami.edu.
authors.forename: Lilian M
authors.initials: LM
authors.lastname: Abbo
authors.affiliation: Division of Infectious Diseases, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1460, Houston, TX 77030, USA.
authors.forename: Ella J
authors.initials: EJ
authors.lastname: Ariza-Heredia
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003141:Communicable Diseases / Q000175:diagnosis / Q000188:drug therapy*; D003955:Diagnostic Tests, Routine / Q000379:methods; D018432:Drug Resistance, Multiple; D004363:Drug Utilization / Q000592:standards*; D042241:Early Diagnosis; D019983:Guideline Adherence / Q000592:standards; D006801:Humans; D016867:Immunocompromised Host; D057970:Inappropriate Prescribing / Q000517:prevention & control*
chemical_list: D000890:Anti-Infective Agents
keywords: Antimicrobial stewardship; Fever; Hematologic malignancies; Immunocompromised; Neutropenia; Solid organ; Transplant